financetom
Business
financetom
/
Business
/
--Street Color: Schlumberger, Canada's Competition Bureau Reach Consent Agreement on ChampionX Takeover
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Street Color: Schlumberger, Canada's Competition Bureau Reach Consent Agreement on ChampionX Takeover
Jul 16, 2025 6:55 AM

09:39 AM EDT, 07/16/2025 (MT Newswires) --

Price: 35.12, Change: +0.04, Percent Change: +0.11

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kane Biotech Secures Approval to Launch Acne Treatment Trial
Kane Biotech Secures Approval to Launch Acne Treatment Trial
Mar 13, 2025
11:14 AM EDT, 03/13/2025 (MT Newswires) -- Kane Biotech ( KNBIF ) on Thursday said it received approval from the Internal Review Board (IRB) of the University of Miami Health System to launch a clinical study of Kane's prototype DispersinB acne cleanser for the treatment of mild to moderate cases of acne vulgaris. The trial, which is expected to start...
Dr. Reddy's Laboratories Recalls Batch of Levetiracetam in 0.75% Sodium Chloride Injection in US
Dr. Reddy's Laboratories Recalls Batch of Levetiracetam in 0.75% Sodium Chloride Injection in US
Mar 13, 2025
11:12 AM EDT, 03/13/2025 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) said Thursday it is recalling one batch of levetiracetam in 0.75% sodium chloride injection, 1,000 mg/100 mL single-dose infusion bags across the US. The company said it is recalling the product due to the incorrect labeling of the infusion bag which reads as levetiracetam in 0.82% sodium chloride injection...
SentinelOne Exceeds Q4 Revenue Expectations, But Guidance Concerns Linger, Oppenheimer Says
SentinelOne Exceeds Q4 Revenue Expectations, But Guidance Concerns Linger, Oppenheimer Says
Mar 13, 2025
11:14 AM EDT, 03/13/2025 (MT Newswires) -- SentinelOne's ( S ) fiscal Q4 revenue exceeded expectations and despite posting strong results near-term investor concerns persist due to lower-than-anticipated guidance for the next fiscal year, Oppenheimer said in a note on Thursday. The company demonstrated strong enterprise adoptions with 1,411 customers generating over $100,000 in annual recurring revenue with 40% of...
Mallinckrodt, Endo Enter $6.7 Billion Merger Deal as Drug Makers Plan New US Listing
Mallinckrodt, Endo Enter $6.7 Billion Merger Deal as Drug Makers Plan New US Listing
Mar 13, 2025
11:01 AM EDT, 03/13/2025 (MT Newswires) -- Mallinckrodt and Endo are set to merge in a cash-and-stock deal valued at $6.7 billion, with the drug makers set to list shares of the new firm on the New York Stock Exchange. Shareholders in Endo, which makes sterile injectables and generic pharmaceuticals, will receive $80 million in cash and a 49.9% stake...
Copyright 2023-2026 - www.financetom.com All Rights Reserved